TMCnet News

New TNMNews Segment Reviews NY's Compassionate Care Act and Treating Veterans' PTSD with Cannabis
[March 06, 2015]

New TNMNews Segment Reviews NY's Compassionate Care Act and Treating Veterans' PTSD with Cannabis


LOS ANGELES, March 6, 2015 /PRNewswire/ -- The latest segment of TNMNews, the unbiased marijuana talk radio program from DigiPath, Inc. (OTCBB and OTCQB: DIGP), goes in-depth into how marijuana legalization is making progress, even in tough states like New York and with veterans. The program will stream at www.tnmnews.com and be broadcast on select terrestrial stations beginning Saturday, March 7, 2015.

The National Marijuana News

"For a long time, the issue of cannabis was clouded with fear and misinformation," explains TNMNews host Todd Denkin. "Now people are becoming more educated about cannabis, and TNMNews is proud to help bring the truth to light."

Julie Netherland, the Deputy State Director for the New York Office of the Drug Policy Alliance, kicks off the show with an overview of the Compassionate Care Act, which permits the production, sale, and use of medical marijuana in New York State. Dr. Netherland says the law, signed into law by Governor Andrew Cuomo in July 2014, was an improvement over former policies, but it is the most restrictive medical marijuana program in the country.

She explains that although cannabis research is proving marijuana effective for treating a large number of medical conditions, New York doctors can only recommend medical marijuana to certain groups of patients. Those patients must use it to treat cancer, HIV/AIDS, ALS, Parkinson's disease, multiple sclerosis, spinal cord damage causing spasticity, epilepsy, inflammatory bowel disease, neuropathies, or Huntington's disease. Smoking cannabis is not allowed, and the Act initially only permits five suppliers to operate a total of 20 facilities.

Next, former Marine Kevin Richardson of the Weed 4 Warriors Project shares his personal story. He developed a dependency on opioid painkillers, which he used to treat his back and lg injuries and PTSD. This ineffective pain treatment led to overdoses and multiple suicide attempts.



Richardson says that micro-dosing cannabis has improved his life and allowed him to get the help and resources he needed to start the healing process. Through his work with the Weed 4 Warriors Project, he hopes to help other veterans who still suffer at great cost. More than 22 veterans commit suicide every day—more than any other group, according to Richardson.

A discussion with Chris, a phone-in caller from Colorado, concludes the segment. He recalls how he stopped using cannabis for recreational purposes five years ago, but after suffering an injury in a car accident, his orthopedic surgeon suggested he try cannabis to treat ongoing pain. He says marijuana edibles are particularly effective for him, much more so than opioid medications, which also gave him unwanted side effects.


To book a guest or advertise on TNMNews.com, please contact:

Martin Wagmaister
[email protected]
(310) 561.6179

About The National Marijuana News
The times are changing, and TNMNews works hard to deliver the news to help you make sense of it all. The medicinal use of marijuana is now legal in 23 States plus the District of Columbia, and recreational use is legal in four states—making cannabis a topic that increasingly demands unbiased examination. TNMNews brings together cannabis-industry and thought leaders to discuss and debate the scientific, medicinal, political, commercial, legal, spiritual, and cultural dimensions of cannabis in today's world.

For more information, go to www.tnmnews.com.

About DigiPath, Inc.
DigiPath, Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the cannabis industry. Our four business units are DigiPath Labs, TNM News Corp., DigiPath Corp., and DigiPath University.

For more information, go to www.digipath.com.

Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements are based on information available at the time they are made, and are subject to risks and uncertainties that could cause actual performance to differ materially from those stated. For a description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

DigiPath, Inc., through its subsidiary, DigiPath, Corp., creates and markets innovative and reliable digital pathology solutions that empower private and academic institutions with the ability to create, store, manage, analyze, and correlate data collected through virtual microscopy. DigiPath, Inc. digital pathology portfolio includes PathScope(TM), PathCloud(TM), PathReview(TM), and PathConsult(TM) digital platforms to share and store archive tissue images. DigiPath, Inc. is expanding into new lines of business associated with the research, development, licensing and operation of botanical and nutrapharmaceutical products and services.

Logo - http://photos.prnewswire.com/prnh/20140605/94753
Logo - http://photos.prnewswire.com/prnh/20141014/151908LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-tnmnews-segment-reviews-nys-compassionate-care-act-and-treating-veterans-ptsd-with-cannabis-300046580.html

SOURCE DigiPath.com


[ Back To TMCnet.com's Homepage ]